Top pharmaceutical companies are moving to a distributed R&D model to drive innovation, with help from the Tetra Data Platform.
Two Boston-based biotechnology companies specializing in gene therapy and precision medicine are leveraging the Tetra Data Platform to streamline collaboration and enable FAIR access to pharmacokinetic and pharmacodynamic results. Read our case study to find out how the Tetra Data Platform supports distributed research and accelerated discovery.
Biotechnology companies can now fully utilize their ADME data across different CROs, including querying and visualization of data sets, using their existing data science and analytics tools.
TetraScience Enables Distributed Research